Faith L. Charles

Board Director

Director

Abeona Therapeutics Inc.Conduit Pharmaceuticals Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 1 saleAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€23k

▼ Sales (2 ops.)

€93k

Latest filing published 27 Jan 2026 for Abeona Therapeutics INC..

Filing timeline

BuySale

Faith L. Charles

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Faith L. Charles: trading record in brief

Faith L. Charles is a declared insider at 2 companies (board member); the most frequent names are Abeona Therapeutics Inc. and CDT Equity Inc. Between 25 May 2021 and 26 January 2026, the trades on record add up to 14 filings.

Market trades split into 1 purchase (€23k) and 2 sales (€93k). On balance, insiders were net sellers of €69k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 11 share grants.

The newest entry dates from 27 January 2026: a share grant, in Abeona Therapeutics Inc. The last purchase on record was published on 29 April 2024, which is 908 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.